fiberoptic endoscopic evaluation of swallowing: Questionnaire, FEES, OPES
Study summary
The present study was designed as a cross-sectional observational study providing the enrollment of tracheostomized patients undergoing major oncological surgery for head-neck cancer.
Aims:
* to provide objective data on the bolus transit during swallowing in tracheostomized patients with tracheal tube and without tracheal tube closing directly the tracheal stoma with a plaster, in order to sustain the choice to preserve the TT in dysphagic patients after oncologic surgery for more security during swallowing rehabilitation or adjuvant treatment.
* to evaluate the features of swallowing, specifically bolus transit, in patients affected by head and neck cancer who underwent major oncological surgery.
Eligibility
Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion criteria
* Age \>18 years
* Tracheal tube diameter of 5.0 mm and outside diameter of 9.4 mm
* Tolerance of the tracheal tube capping for almost 48 hours without pathologic desaturation during continue monitoring of SpO2
* Ability to swallow in accordance to the inpatient training program
* Ability to suck with a straw without oral leakage Exclusion criteria
* Previous head and neck radiotherapy
* Patients with nasal tube feeding
* Patients with poor cognition or poor general condition or affected by neurological o other nontumor-related dysphagia
* Patients total laryngectomized
* Patients unable to maintain the orthostatic position
Primary outcome measure(s)
To provide objective data on the bolus transit during swallowing in tracheostomized patients with tracheal tube and without tracheal tube — five years To provide objective data on the bolus transit during swallowing in tracheostomized patients with tracheal tube and without tracheal tube closing directly the tracheal stoma with a plaster, in order to sustain the choice to preserve the TT in dysphagic patients after oncologic surgery for more security during swallowing rehabilitation or adjuvant treatment.
Trial sites (1)
Facility
City
Region
Status
Maria Raffaella Marchese
Roma
Italy
Recruiting
More Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
